Weam Aldiban: The Critical Impact of Pharmacogenetic Variation on Dabigatran Exposure and Bleeding Risk
Weam Aldiban, Head of Pharmacology & Toxicology Department at IUST University, shared a post on LinkedIn:
“Excited to share our latest publication in Human Genomics!
Title: The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis
Our study highlights the critical impact of pharmacogenetic variation on dabigatran exposure and bleeding risk. Key findings include:
– ABCB1 rs/148738 CT/TT genotypes → lower trough concentrations
– CES1 rs8192935 GG genotype → increased peak concentrations
– CES1 rs2244613 TT genotype → elevated peak/trough levels and bleeding risk
– CES1 rs2244613 GT genotype → increased trough levels only
These insights underscore the importance of personalized medicine in anticoagulant therapy and call for large-scale prospective studies across diverse populations to validate and expand upon our findings.
Grateful to our team and collaborators for their dedication and rigor. Let’s keep pushing the boundaries of precision pharmacotherapy!”
Title: The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis
Authors: Weam Aldiban, Nada G. Hamam, Nereen A. Almosilhy, Kholoud Elsamman, Mohamed Wagdy, Doaa Mashaly, Suhel F. Batarseh, Youssef El-Sherif, Basma Badrawy Khalefa, Zina Otmani
Read full paper here.
Stay informed with Hemostasis Today.
-
Aug 22, 2026, 17:27Masudah Paleker: Suboptimal Warfarin Control in South Africa
-
Aug 22, 2026, 17:26Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:19Moti Haim: Transforming AF Care in the Elderly
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination